Global HIV Antivirals Supply, Demand and Key Producers, 2024-2030
Page: 112
Published Date: 06 Sep 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
HIV antivirals are medications used to manage HIV infection by inhibiting the virus's ability to replicate and spread. They work by targeting different stages of the HIV life cycle. These drugs are often used in combination to effectively control the virus and improve the quality of life for people living with HIV.
The global HIV Antivirals market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).
This report studies the global HIV Antivirals production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for HIV Antivirals and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of HIV Antivirals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global HIV Antivirals total production and demand, 2019-2030, (K Units)
Global HIV Antivirals total production value, 2019-2030, (USD Million)
Global HIV Antivirals production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global HIV Antivirals consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: HIV Antivirals domestic production, consumption, key domestic manufacturers and share
Global HIV Antivirals production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global HIV Antivirals production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global HIV Antivirals production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global HIV Antivirals market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, ViiV Healthcare, Johnson & Johnson (Janssen Pharmaceuticals), Merck & Co., AbbVie, Bristol-Myers Squibb, Roche, Teva Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World HIV Antivirals market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global HIV Antivirals Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global HIV Antivirals Market, Segmentation by Type:
Fixed Dose Combinations (FDCs)
Integrase Strand Transfer Inhibitors (lNSTls)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTls)
Entry Inhibitors -CCR5 co-receptor antagonist
Protease Inhibitors (Pls)
Nucleoside Reverse Transcriptase lnhibitors (NRTls)
Others
Global HIV Antivirals Market, Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Companies Profiled:
Gilead Sciences
ViiV Healthcare
Johnson & Johnson (Janssen Pharmaceuticals)
Merck & Co.
AbbVie
Bristol-Myers Squibb
Roche
Teva Pharmaceuticals
Key Questions Answered:
1. How big is the global HIV Antivirals market?
2. What is the demand of the global HIV Antivirals market?
3. What is the year over year growth of the global HIV Antivirals market?
4. What is the production and production value of the global HIV Antivirals market?
5. Who are the key producers in the global HIV Antivirals market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 HIV Antivirals Introduction
1.2 World HIV Antivirals Supply & Forecast
1.2.1 World HIV Antivirals Production Value (2019 & 2023 & 2030)
1.2.2 World HIV Antivirals Production (2019-2030)
1.2.3 World HIV Antivirals Pricing Trends (2019-2030)
1.3 World HIV Antivirals Production by Region (Based on Production Site)
1.3.1 World HIV Antivirals Production Value by Region (2019-2030)
1.3.2 World HIV Antivirals Production by Region (2019-2030)
1.3.3 World HIV Antivirals Average Price by Region (2019-2030)
1.3.4 North America HIV Antivirals Production (2019-2030)
1.3.5 Europe HIV Antivirals Production (2019-2030)
1.3.6 China HIV Antivirals Production (2019-2030)
1.3.7 Japan HIV Antivirals Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 HIV Antivirals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 HIV Antivirals Major Market Trends
2 Demand Summary
2.1 World HIV Antivirals Demand (2019-2030)
2.2 World HIV Antivirals Consumption by Region
2.2.1 World HIV Antivirals Consumption by Region (2019-2024)
2.2.2 World HIV Antivirals Consumption Forecast by Region (2025-2030)
2.3 United States HIV Antivirals Consumption (2019-2030)
2.4 China HIV Antivirals Consumption (2019-2030)
2.5 Europe HIV Antivirals Consumption (2019-2030)
2.6 Japan HIV Antivirals Consumption (2019-2030)
2.7 South Korea HIV Antivirals Consumption (2019-2030)
2.8 ASEAN HIV Antivirals Consumption (2019-2030)
2.9 India HIV Antivirals Consumption (2019-2030)
3 World Manufacturers Competitive Analysis
3.1 World HIV Antivirals Production Value by Manufacturer (2019-2024)
3.2 World HIV Antivirals Production by Manufacturer (2019-2024)
3.3 World HIV Antivirals Average Price by Manufacturer (2019-2024)
3.4 HIV Antivirals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global HIV Antivirals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for HIV Antivirals in 2023
3.5.3 Global Concentration Ratios (CR8) for HIV Antivirals in 2023
3.6 HIV Antivirals Market: Overall Company Footprint Analysis
3.6.1 HIV Antivirals Market: Region Footprint
3.6.2 HIV Antivirals Market: Company Product Type Footprint
3.6.3 HIV Antivirals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: HIV Antivirals Production Value Comparison
4.1.1 United States VS China: HIV Antivirals Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: HIV Antivirals Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: HIV Antivirals Production Comparison
4.2.1 United States VS China: HIV Antivirals Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: HIV Antivirals Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: HIV Antivirals Consumption Comparison
4.3.1 United States VS China: HIV Antivirals Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: HIV Antivirals Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based HIV Antivirals Manufacturers and Market Share, 2019-2024
4.4.1 United States Based HIV Antivirals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers HIV Antivirals Production Value (2019-2024)
4.4.3 United States Based Manufacturers HIV Antivirals Production (2019-2024)
4.5 China Based HIV Antivirals Manufacturers and Market Share
4.5.1 China Based HIV Antivirals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers HIV Antivirals Production Value (2019-2024)
4.5.3 China Based Manufacturers HIV Antivirals Production (2019-2024)
4.6 Rest of World Based HIV Antivirals Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based HIV Antivirals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers HIV Antivirals Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers HIV Antivirals Production (2019-2024)
5 Market Analysis by Type
5.1 World HIV Antivirals Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Fixed Dose Combinations (FDCs)
5.2.2 Integrase Strand Transfer Inhibitors (lNSTls)
5.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTls)
5.2.4 Entry Inhibitors -CCR5 co-receptor antagonist
5.2.5 Protease Inhibitors (Pls)
5.2.6 Nucleoside Reverse Transcriptase lnhibitors (NRTls)
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World HIV Antivirals Production by Type (2019-2030)
5.3.2 World HIV Antivirals Production Value by Type (2019-2030)
5.3.3 World HIV Antivirals Average Price by Type (2019-2030)
6 Market Analysis by Application
6.1 World HIV Antivirals Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Segment by Application
6.3.1 World HIV Antivirals Production by Application (2019-2030)
6.3.2 World HIV Antivirals Production Value by Application (2019-2030)
6.3.3 World HIV Antivirals Average Price by Application (2019-2030)
7 Company Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Details
7.1.2 Gilead Sciences Major Business
7.1.3 Gilead Sciences HIV Antivirals Product and Services
7.1.4 Gilead Sciences HIV Antivirals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Gilead Sciences Recent Developments/Updates
7.1.6 Gilead Sciences Competitive Strengths & Weaknesses
7.2 ViiV Healthcare
7.2.1 ViiV Healthcare Details
7.2.2 ViiV Healthcare Major Business
7.2.3 ViiV Healthcare HIV Antivirals Product and Services
7.2.4 ViiV Healthcare HIV Antivirals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 ViiV Healthcare Recent Developments/Updates
7.2.6 ViiV Healthcare Competitive Strengths & Weaknesses
7.3 Johnson & Johnson (Janssen Pharmaceuticals)
7.3.1 Johnson & Johnson (Janssen Pharmaceuticals) Details
7.3.2 Johnson & Johnson (Janssen Pharmaceuticals) Major Business
7.3.3 Johnson & Johnson (Janssen Pharmaceuticals) HIV Antivirals Product and Services
7.3.4 Johnson & Johnson (Janssen Pharmaceuticals) HIV Antivirals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments/Updates
7.3.6 Johnson & Johnson (Janssen Pharmaceuticals) Competitive Strengths & Weaknesses
7.4 Merck & Co.
7.4.1 Merck & Co. Details
7.4.2 Merck & Co. Major Business
7.4.3 Merck & Co. HIV Antivirals Product and Services
7.4.4 Merck & Co. HIV Antivirals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Merck & Co. Recent Developments/Updates
7.4.6 Merck & Co. Competitive Strengths & Weaknesses
7.5 AbbVie
7.5.1 AbbVie Details
7.5.2 AbbVie Major Business
7.5.3 AbbVie HIV Antivirals Product and Services
7.5.4 AbbVie HIV Antivirals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 AbbVie Recent Developments/Updates
7.5.6 AbbVie Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Details
7.6.2 Bristol-Myers Squibb Major Business
7.6.3 Bristol-Myers Squibb HIV Antivirals Product and Services
7.6.4 Bristol-Myers Squibb HIV Antivirals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Bristol-Myers Squibb Recent Developments/Updates
7.6.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.7 Roche
7.7.1 Roche Details
7.7.2 Roche Major Business
7.7.3 Roche HIV Antivirals Product and Services
7.7.4 Roche HIV Antivirals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Roche Recent Developments/Updates
7.7.6 Roche Competitive Strengths & Weaknesses
7.8 Teva Pharmaceuticals
7.8.1 Teva Pharmaceuticals Details
7.8.2 Teva Pharmaceuticals Major Business
7.8.3 Teva Pharmaceuticals HIV Antivirals Product and Services
7.8.4 Teva Pharmaceuticals HIV Antivirals Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Teva Pharmaceuticals Recent Developments/Updates
7.8.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 HIV Antivirals Industry Chain
8.2 HIV Antivirals Upstream Analysis
8.2.1 HIV Antivirals Core Raw Materials
8.2.2 Main Manufacturers of HIV Antivirals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 HIV Antivirals Production Mode
8.6 HIV Antivirals Procurement Model
8.7 HIV Antivirals Industry Sales Model and Sales Channels
8.7.1 HIV Antivirals Sales Model
8.7.2 HIV Antivirals Typical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World HIV Antivirals Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World HIV Antivirals Production Value by Region (2019-2024) & (USD Million)
Table 3. World HIV Antivirals Production Value by Region (2025-2030) & (USD Million)
Table 4. World HIV Antivirals Production Value Market Share by Region (2019-2024)
Table 5. World HIV Antivirals Production Value Market Share by Region (2025-2030)
Table 6. World HIV Antivirals Production by Region (2019-2024) & (K Units)
Table 7. World HIV Antivirals Production by Region (2025-2030) & (K Units)
Table 8. World HIV Antivirals Production Market Share by Region (2019-2024)
Table 9. World HIV Antivirals Production Market Share by Region (2025-2030)
Table 10. World HIV Antivirals Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World HIV Antivirals Average Price by Region (2025-2030) & (US$/Unit)
Table 12. HIV Antivirals Major Market Trends
Table 13. World HIV Antivirals Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World HIV Antivirals Consumption by Region (2019-2024) & (K Units)
Table 15. World HIV Antivirals Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World HIV Antivirals Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key HIV Antivirals Producers in 2023
Table 18. World HIV Antivirals Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key HIV Antivirals Producers in 2023
Table 20. World HIV Antivirals Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global HIV Antivirals Company Evaluation Quadrant
Table 22. World HIV Antivirals Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and HIV Antivirals Production Site of Key Manufacturer
Table 24. HIV Antivirals Market: Company Product Type Footprint
Table 25. HIV Antivirals Market: Company Product Application Footprint
Table 26. HIV Antivirals Competitive Factors
Table 27. HIV Antivirals New Entrant and Capacity Expansion Plans
Table 28. HIV Antivirals Mergers & Acquisitions Activity
Table 29. United States VS China HIV Antivirals Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China HIV Antivirals Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China HIV Antivirals Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based HIV Antivirals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers HIV Antivirals Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers HIV Antivirals Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers HIV Antivirals Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers HIV Antivirals Production Market Share (2019-2024)
Table 37. China Based HIV Antivirals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers HIV Antivirals Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers HIV Antivirals Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers HIV Antivirals Production, (2019-2024) & (K Units)
Table 41. China Based Manufacturers HIV Antivirals Production Market Share (2019-2024)
Table 42. Rest of World Based HIV Antivirals Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers HIV Antivirals Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers HIV Antivirals Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers HIV Antivirals Production, (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers HIV Antivirals Production Market Share (2019-2024)
Table 47. World HIV Antivirals Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World HIV Antivirals Production by Type (2019-2024) & (K Units)
Table 49. World HIV Antivirals Production by Type (2025-2030) & (K Units)
Table 50. World HIV Antivirals Production Value by Type (2019-2024) & (USD Million)
Table 51. World HIV Antivirals Production Value by Type (2025-2030) & (USD Million)
Table 52. World HIV Antivirals Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World HIV Antivirals Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World HIV Antivirals Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World HIV Antivirals Production by Application (2019-2024) & (K Units)
Table 56. World HIV Antivirals Production by Application (2025-2030) & (K Units)
Table 57. World HIV Antivirals Production Value by Application (2019-2024) & (USD Million)
Table 58. World HIV Antivirals Production Value by Application (2025-2030) & (USD Million)
Table 59. World HIV Antivirals Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World HIV Antivirals Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 62. Gilead Sciences Major Business
Table 63. Gilead Sciences HIV Antivirals Product and Services
Table 64. Gilead Sciences HIV Antivirals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Gilead Sciences Recent Developments/Updates
Table 66. Gilead Sciences Competitive Strengths & Weaknesses
Table 67. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. ViiV Healthcare Major Business
Table 69. ViiV Healthcare HIV Antivirals Product and Services
Table 70. ViiV Healthcare HIV Antivirals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. ViiV Healthcare Recent Developments/Updates
Table 72. ViiV Healthcare Competitive Strengths & Weaknesses
Table 73. Johnson & Johnson (Janssen Pharmaceuticals) Basic Information, Manufacturing Base and Competitors
Table 74. Johnson & Johnson (Janssen Pharmaceuticals) Major Business
Table 75. Johnson & Johnson (Janssen Pharmaceuticals) HIV Antivirals Product and Services
Table 76. Johnson & Johnson (Janssen Pharmaceuticals) HIV Antivirals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments/Updates
Table 78. Johnson & Johnson (Janssen Pharmaceuticals) Competitive Strengths & Weaknesses
Table 79. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 80. Merck & Co. Major Business
Table 81. Merck & Co. HIV Antivirals Product and Services
Table 82. Merck & Co. HIV Antivirals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Merck & Co. Recent Developments/Updates
Table 84. Merck & Co. Competitive Strengths & Weaknesses
Table 85. AbbVie Basic Information, Manufacturing Base and Competitors
Table 86. AbbVie Major Business
Table 87. AbbVie HIV Antivirals Product and Services
Table 88. AbbVie HIV Antivirals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. AbbVie Recent Developments/Updates
Table 90. AbbVie Competitive Strengths & Weaknesses
Table 91. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Major Business
Table 93. Bristol-Myers Squibb HIV Antivirals Product and Services
Table 94. Bristol-Myers Squibb HIV Antivirals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Bristol-Myers Squibb Recent Developments/Updates
Table 96. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 97. Roche Basic Information, Manufacturing Base and Competitors
Table 98. Roche Major Business
Table 99. Roche HIV Antivirals Product and Services
Table 100. Roche HIV Antivirals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Roche Recent Developments/Updates
Table 102. Roche Competitive Strengths & Weaknesses
Table 103. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Teva Pharmaceuticals Major Business
Table 105. Teva Pharmaceuticals HIV Antivirals Product and Services
Table 106. Teva Pharmaceuticals HIV Antivirals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Teva Pharmaceuticals Recent Developments/Updates
Table 108. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Global Key Players of HIV Antivirals Upstream (Raw Materials)
Table 110. Global HIV Antivirals Typical Customers
Table 111. HIV Antivirals Typical Distributors
List of Figures
Figure 1. HIV Antivirals Picture
Figure 2. World HIV Antivirals Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World HIV Antivirals Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World HIV Antivirals Production (2019-2030) & (K Units)
Figure 5. World HIV Antivirals Average Price (2019-2030) & (US$/Unit)
Figure 6. World HIV Antivirals Production Value Market Share by Region (2019-2030)
Figure 7. World HIV Antivirals Production Market Share by Region (2019-2030)
Figure 8. North America HIV Antivirals Production (2019-2030) & (K Units)
Figure 9. Europe HIV Antivirals Production (2019-2030) & (K Units)
Figure 10. China HIV Antivirals Production (2019-2030) & (K Units)
Figure 11. Japan HIV Antivirals Production (2019-2030) & (K Units)
Figure 12. HIV Antivirals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World HIV Antivirals Consumption (2019-2030) & (K Units)
Figure 15. World HIV Antivirals Consumption Market Share by Region (2019-2030)
Figure 16. United States HIV Antivirals Consumption (2019-2030) & (K Units)
Figure 17. China HIV Antivirals Consumption (2019-2030) & (K Units)
Figure 18. Europe HIV Antivirals Consumption (2019-2030) & (K Units)
Figure 19. Japan HIV Antivirals Consumption (2019-2030) & (K Units)
Figure 20. South Korea HIV Antivirals Consumption (2019-2030) & (K Units)
Figure 21. ASEAN HIV Antivirals Consumption (2019-2030) & (K Units)
Figure 22. India HIV Antivirals Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of HIV Antivirals by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for HIV Antivirals Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for HIV Antivirals Markets in 2023
Figure 26. United States VS China: HIV Antivirals Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: HIV Antivirals Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: HIV Antivirals Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers HIV Antivirals Production Market Share 2023
Figure 30. China Based Manufacturers HIV Antivirals Production Market Share 2023
Figure 31. Rest of World Based Manufacturers HIV Antivirals Production Market Share 2023
Figure 32. World HIV Antivirals Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World HIV Antivirals Production Value Market Share by Type in 2023
Figure 34. Fixed Dose Combinations (FDCs)
Figure 35. Integrase Strand Transfer Inhibitors (lNSTls)
Figure 36. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTls)
Figure 37. Entry Inhibitors -CCR5 co-receptor antagonist
Figure 38. Protease Inhibitors (Pls)
Figure 39. Nucleoside Reverse Transcriptase lnhibitors (NRTls)
Figure 40. Others
Figure 41. World HIV Antivirals Production Market Share by Type (2019-2030)
Figure 42. World HIV Antivirals Production Value Market Share by Type (2019-2030)
Figure 43. World HIV Antivirals Average Price by Type (2019-2030) & (US$/Unit)
Figure 44. World HIV Antivirals Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 45. World HIV Antivirals Production Value Market Share by Application in 2023
Figure 46. Hospital Pharmacies
Figure 47. Retail Pharmacies
Figure 48. Online Pharmacies
Figure 49. World HIV Antivirals Production Market Share by Application (2019-2030)
Figure 50. World HIV Antivirals Production Value Market Share by Application (2019-2030)
Figure 51. World HIV Antivirals Average Price by Application (2019-2030) & (US$/Unit)
Figure 52. HIV Antivirals Industry Chain
Figure 53. HIV Antivirals Procurement Model
Figure 54. HIV Antivirals Sales Model
Figure 55. HIV Antivirals Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Gilead Sciences ViiV Healthcare Johnson & Johnson (Janssen Pharmaceuticals) Merck & Co. AbbVie Bristol-Myers Squibb Roche Teva Pharmaceuticals
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>